Member LoginDividend CushionValue Trap |
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
Jul 14, 2012
Wells Fargo Continues Its Sound Performance
Warren Buffett favorite Wells Fargo posted another solid quarter. We like the bank's conservative ethos but think shares are fairly valued. Jul 13, 2012
Jamie Dimon Continues To Be the Model CEO
Jamie Dimon, CEO of JP Morgan Chase, seems to have successfully navigated his firm through difficult trading losses with honesty and transparency. We think shares of JP Morgan remain undervalued. Jul 13, 2012
Fastenal Shrugs Off Economic Slowdown
Industrial distributor Fastenal continues to grow and capitalize on industrial production in the United States. Still, we think shares are fairly valued. Jul 12, 2012
SuperValu’s Dividend Cut Could Help The Grocer Survive
Grocer SuperValu reported a poor quarter and announced it will cut its dividend. We think shares of the grocer are undervalued, but a bit too risky for us. Jul 12, 2012
We Agree With Abercrombie & Fitch: Its Stock Is Cheap
Reports are surfacing that the teen retailer will announce a plan to repurchase up to 15% of its stock. We generally don't like teen retail, but Ambercrombie & Fitch is cheap. Still, we'd wait for a better score on our Valuentum Buying Index. Jul 10, 2012
AMD Warns On Revenue, We Like Intel Instead
Chipmaker AMD pre-announced poor results for its second-quarter revenue. We suspect earnings will also be poor, but we still like Intel. Jul 10, 2012
Alcoa Beats Estimates But We Don’t Like the Stock
Aluminum giant Alcoa reported better than expected results. We think shares are fairly valued. Jul 9, 2012
Ashford University is Denied Accreditation; We’d Continue to Stay Away From Bridgepoint
For-profit education provider Bridgepoint saw one of its schools, Ashford University, denied accreditation. We'd continue to steer clear of Bridgepoint and other for-profit education firms. Jul 9, 2012
WellPoint Bets on Medicare and Medicaid
Health benefits company WellPoint will acquire managed care provider Amerigroup, as the company positions itself to take advantage of Medicare and Medicaid expansion. Jul 9, 2012
Thompson Reuters’ Acquisition of FX Alliance Points to Growing Interest in Alternative Investments
Investment data provider Thompson Reuters acquired FX Alliance as currencies and precious metals become more popular with institutional investors.
prev12345678910111213141516171819202122232425
26272829303132333435363738394041424344454647484950 51525354555657585960616263646566676869707172737475 767778798081828384858687888990919293949596979899100 101102103104105106107108109110111112113114115116117118119120 121122123124125126127128129130131132133134135136137138139140 141142143144145146147148149150151152153154155156157158159160 161162163164165166167168169170171172173174175176177178179180 181182183184185186187188189190191192193194195196197198199200 201202203204205206207208209210211212213214215216217218219220 221222223224225226227228229230231232233234235236237238239240 241242243244245246247248249250251252253254255256257258259260 261262263264265266267268269270271272273274275276277278279280 281282283284285286287288289290291292293294295296297298299300 301302303304305306307308309310311312313314315316317318319320 321322323324325326327328329330331332333334335336337338339340 341342343344345346347348349350351352353next The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|